Symphony Environmental Technologies Plc, global specialists in advanced plastics and tyre recycling technologies, has signed a five year supply and marketing agreement with the Belgium company Janssen Pharmaceutica, a division of Johnson & Johnson, one of the world’s largest pharmaceutical and healthcare companies. The agreement covers an important breakthrough in anti-fungal and anti-bacterial technology for plastic applications.
Janssen PMP (a division of Janssen Pharmaceutica) and Symphony have been working together for the past two years to introduce a master batch which can be put into plastic products at the manufacturing stage to control dangerous bacteria. The master batch will provide better protection against bacteria, fungi, moulds, mildew and algae for plastics including packaging, agriculture and fisheries products, semi rigid and rigid containers, medical instruments and pipes. The agreement provides Symphony with distribution and marketing rights in a large number of countries. The product will be sold by Symphony and co-branded under the d2p brand name.
The need for this type of technology was highlighted by the UK Chief Medical Officer’s warning in March 2013 that there is a catastrophic threat of resistance to antibiotics. Also, the British Broadcast Corporation (BBC) has reported that between 30% and 50% of the world’s four billion tonnes of food products goes to waste each year.